• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Sem:一款适用于肿瘤学研究的统计软件] 。 (注:原英文句子中adaptated拼写错误,正确应为adapted)

[Sem: a suitable statistical software adaptated for research in oncology].

作者信息

Kwiatkowski F, Girard M, Hacene K, Berlie J

机构信息

Centre Jean-Perrin, Unité de bio-statistiques, rue Montalembert, BP 392, 63011 Clermont-Ferrand Cedex.

出版信息

Bull Cancer. 2000 Oct;87(10):715-21.

PMID:11084535
Abstract

Many softwares have been adapted for medical use; they rarely enable conveniently both data management and statistics. A recent cooperative work ended up in a new software, Sem (Statistics Epidemiology Medicine), which allows data management of trials and, as well, statistical treatments on them. Very convenient, it can be used by non professional in statistics (biologists, doctors, researchers, data managers), since usually (excepted with multivariate models), the software performs by itself the most adequate test, after what complementary tests can be requested if needed. Sem data base manager (DBM) is not compatible with usual DBM: this constitutes a first protection against loss of privacy. Other shields (passwords, cryptage...) strengthen data security, all the more necessary today since Sem can be run on computers nets. Data organization enables multiplicity: forms can be duplicated by patient. Dates are treated in a special but transparent manner (sorting, date and delay calculations...). Sem communicates with common desktop softwares, often with a simple copy/paste. So, statistics can be easily performed on data stored in external calculation sheets, and slides by pasting graphs with a single mouse click (survival curves...). Already used over fifty places in different hospitals for daily work, this product, combining data management and statistics, appears to be a convenient and innovative solution.

摘要

许多软件已被改编用于医学领域;但它们很少能同时方便地进行数据管理和统计分析。最近的一项合作成果是一款新软件Sem(统计流行病学医学软件),它可以对试验数据进行管理,并对这些数据进行统计处理。该软件非常便捷,非统计专业人员(生物学家、医生、研究人员、数据管理员)也能使用,因为通常情况下(多元模型除外),软件会自行执行最合适的测试,如有需要还可要求进行补充测试。Sem数据库管理器(DBM)与常用的DBM不兼容:这是防止隐私泄露的第一道防线。其他防护措施(密码、加密等)加强了数据安全性,如今这一点更加必要,因为Sem可以在计算机网络上运行。数据组织方式具有多样性:表单可以按患者进行复制。日期处理方式特殊但直观(排序、日期和时间间隔计算等)。Sem可以与常见的桌面软件通信,通常只需简单的复制/粘贴操作。因此,可以轻松地对外部计算表中存储的数据进行统计分析,通过单次鼠标点击粘贴图表(生存曲线等)即可生成幻灯片。该产品已在不同医院的五十多个地方用于日常工作,它将数据管理和统计分析相结合,似乎是一个方便且创新的解决方案。

相似文献

1
[Sem: a suitable statistical software adaptated for research in oncology].[Sem:一款适用于肿瘤学研究的统计软件] 。 (注:原英文句子中adaptated拼写错误,正确应为adapted)
Bull Cancer. 2000 Oct;87(10):715-21.
2
American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.美国临床肿瘤学会政策声明更新:癌症易感性基因检测
J Clin Oncol. 2003 Jun 15;21(12):2397-406. doi: 10.1200/JCO.2003.03.189. Epub 2003 Apr 11.
3
Remote access methods for exploratory data analysis and statistical modelling: Privacy-Preserving Analytics.用于探索性数据分析和统计建模的远程访问方法:隐私保护分析
Comput Methods Programs Biomed. 2008 Sep;91(3):208-22. doi: 10.1016/j.cmpb.2008.04.001. Epub 2008 May 20.
4
Software for tabular data protection.表格数据保护软件。
Stat Med. 2005 Feb 28;24(4):659-69. doi: 10.1002/sim.2043.
5
Using software agents to preserve individual health data confidentiality in micro-scale geographical analyses.在微观地理分析中使用软件代理保护个人健康数据的保密性。
J Biomed Inform. 2006 Apr;39(2):160-70. doi: 10.1016/j.jbi.2005.06.003. Epub 2005 Jul 26.
6
Web-based secure access from multiple patient repositories.基于网络的来自多个患者资料库的安全访问。
Int J Med Inform. 2008 Apr;77(4):242-8. doi: 10.1016/j.ijmedinf.2007.06.001. Epub 2007 Aug 2.
7
Telecardiology for effective healthcare services.用于有效医疗服务的远程心脏病学。
J Med Eng Technol. 2003 Jul-Aug;27(4):149-59. doi: 10.1080/0309190031000087298.
8
[Major statistical software usable in epidemiology].[可用于流行病学的主要统计软件]
Rev Epidemiol Sante Publique. 1998 Sep;46(4):329-36.
9
Access and privacy rights using web security standards to increase patient empowerment.利用网络安全标准保障访问和隐私权,增强患者自主权。
Stud Health Technol Inform. 2008;137:275-85.
10
[Electronic medical records: medical and legal aspects, privacy, safety, and legal validity].[电子病历:医学与法律层面、隐私、安全及法律效力]
Ital Heart J Suppl. 2001 Mar;2(3):268-86.

引用本文的文献

1
Curcumin's effect in advanced and metastatic breast cancer patients treated with first or second-line docetaxel: A randomized trial.姜黄素对接受一线或二线多西他赛治疗的晚期和转移性乳腺癌患者的疗效:一项随机试验。
Health Sci Rep. 2024 Sep 16;7(9):e70052. doi: 10.1002/hsr2.70052. eCollection 2024 Sep.
2
Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker.晚期非小细胞肺癌的端粒状态提供了一种新的有前景的预后和预测生物标志物。
Cancers (Basel). 2022 Dec 31;15(1):290. doi: 10.3390/cancers15010290.
3
Benefits of using corneal topography to choose subjective refraction technique in keratoconus (RE-CON): a prospective comparative crossover clinical study.
角膜地形测量在圆锥角膜患者主观验光技术选择中的优势(RE-CON):一项前瞻性对比交叉临床研究。
Graefes Arch Clin Exp Ophthalmol. 2022 Jan;260(1):197-207. doi: 10.1007/s00417-021-05382-y. Epub 2021 Aug 20.
4
Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first-line treatment of metastatic castration-resistant prostate cancer.多中心随机 II 期研究比较多西他赛联合姜黄素与多西他赛联合安慰剂一线治疗转移性去势抵抗性前列腺癌。
Cancer Med. 2021 Apr;10(7):2332-2340. doi: 10.1002/cam4.3806. Epub 2021 Mar 5.
5
Risk Factors Associated With Complications After Unilateral Immediate Breast Reconstruction: A French Prospective Multicenter Study.单侧即刻乳房重建术后并发症的相关危险因素:一项法国前瞻性多中心研究。
In Vivo. 2021 Mar-Apr;35(2):937-945. doi: 10.21873/invivo.12334.
6
Effectiveness of a Global Multidisciplinary Supportive and Educational Intervention in Thermal Resort on Anthropometric and Biological Parameters, and the Disease-Free Survival after Breast Cancer Treatment Completion (PACThe).全球多学科支持与教育干预在温泉度假区对人体测量和生物学参数以及乳腺癌治疗结束后无病生存期的效果(PACThe)
J Oncol. 2020 May 5;2020:4181850. doi: 10.1155/2020/4181850. eCollection 2020.
7
Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells.吉非替尼和依维莫司联合靶向 EGFR 和 mTOR 治疗三阴性乳腺癌细胞。
Sci Rep. 2020 Apr 14;10(1):6367. doi: 10.1038/s41598-020-63310-2.
8
Decision of adjuvant chemotherapy in intermediate risk luminal breast cancer patients: A prospective multicenter trial assessing the clinical and psychological impact of EndoPredict® (EpClin) use (UCBG 2-14).辅助化疗在中危 luminal 型乳腺癌患者中的决策:一项前瞻性多中心试验,评估 EndoPredict®(EpClin)使用(UCBG 2-14)的临床和心理影响。
Breast. 2020 Feb;49:132-140. doi: 10.1016/j.breast.2019.10.013. Epub 2019 Nov 14.
9
Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.年龄、甲状腺球蛋白水平和 ATA 风险分层预测分化型甲状腺癌患者的 10 年生存率。
PLoS One. 2019 Aug 19;14(8):e0221298. doi: 10.1371/journal.pone.0221298. eCollection 2019.
10
BRACAVENIR: an observational study of expectations and coping in young women with high hereditary risk of breast and ovarian cancer.BRACAVENIR:一项针对具有高遗传性乳腺癌和卵巢癌风险的年轻女性的期望与应对方式的观察性研究。
Hered Cancer Clin Pract. 2019 Feb 27;17:7. doi: 10.1186/s13053-019-0107-7. eCollection 2019.